JBM (Healthcare) (HKSE:02161) Dividend Payout Ratio: 0.93 (As of Mar. 2026) — 127% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02161 JBM (Healthcare) Ltd HKSE:02161
86 GF Score
Price HK$1.92
GF Value HK$2.08
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is JBM (Healthcare) Dividend Payout Ratio?

JBM (Healthcare) HKSE:02161 -1.03% 86 Dividend Payout Ratio is 0.93 as of Mar. 2026, which is 127% above its 10-year median of 0.41. GuruFocus rates HKSE:02161 with a GF Score™ of 86/100 and a GF Value™ of HK$2.08 (Fairly Valued). The stock has 4 warning signs investors should review. Among 446 Drug Manufacturers companies, JBM (Healthcare) ranks worse than 87.44% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. JBM (Healthcare)'s Dividend Payout Ratio for the months ended in Mar. 2026 was 0.93.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of JBM (Healthcare) Ltd is 0.86, which seems too high.

The historical rank and industry rank for JBM (Healthcare)'s Dividend Payout Ratio or its related term are showing as below:

HKSE:02161' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.09   Med: 0.41   Max: 0.86
Current: 0.86

During the past 9 years, the highest Dividend Payout Ratio of JBM (Healthcare) was 0.86. The lowest was 0.09. And the median was 0.41.

HKSE:02161's Dividend Payout Ratio is ranked worse than
87.44% of 446 companies
in the Drug Manufacturers industry
Industry Median: 0.385 vs HKSE:02161: 0.86

As of today (2026-08-04), the Dividend Yield % of JBM (Healthcare) is 11.06%.

During the past 9 years, the highest Trailing Annual Dividend Yield of JBM (Healthcare) was 11.27%. The lowest was 0.38%. And the median was 3.33%.

JBM (Healthcare)'s Dividends per Share for the months ended in Mar. 2026 was HK$0.10.

During the past 12 months, JBM (Healthcare)'s average Dividends Per Share Growth Rate was 121.90% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 249.30% per year.

During the past 9 years, the highest 3-Year average Dividends Per Share Growth Rate of JBM (Healthcare) was 249.30% per year. The lowest was 249.30% per year. And the median was 249.30% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

JBM (Healthcare) (HKSE:02161) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

JBM (Healthcare) Dividend Payout Ratio Related Terms

JBM (Healthcare) Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for JBM (Healthcare)'s Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JBM (Healthcare) Dividend Payout Ratio Chart

JBM (Healthcare) Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only 0.00 0.09 0.42 0.40 0.86

JBM (Healthcare) Semi-Annual Data
Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.36 0.44 0.82 0.93

HKSE:02161 vs ZTS: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, JBM (Healthcare)'s Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JBM (Healthcare) Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JBM (Healthcare)'s Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where JBM (Healthcare)'s Dividend Payout Ratio falls into.


HKSE:02161
86GF Score
JBM (Healthcare) Ltd HKSE:02161
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JBM (Healthcare) Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

JBM (Healthcare)'s Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2026 )/ EPS without NRI (A: Mar. 2026 )
=0.213/ 0.247
=0.86

JBM (Healthcare)'s Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0.098/ 0.106
=0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.93 mean?
JBM (Healthcare) (HKSE:02161) has a Dividend Payout Ratio of 0.93 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on JBM (Healthcare) and its competitors. This is 127% above median its historical median of 0.41. Over the past decade, JBM (Healthcare)'s Dividend Payout Ratio has ranged from 0.09 to 0.86. According to the industry distribution chart, JBM (Healthcare) ranks #390 out of 446 companies in the Drug Manufacturers industry, placing it in the top 87.4%.
Is JBM (Healthcare)'s Dividend Payout Ratio too high?
JBM (Healthcare)'s current Dividend Payout Ratio of 0.93 is 127% above median its 10-year median of 0.41. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 0.86. The Drug Manufacturers industry median Dividend Payout Ratio is 0.39. JBM (Healthcare)'s value of 0.93 is 141.6% above this industry median. Based on the distribution chart, JBM (Healthcare) ranks #390 out of 446 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, JBM (Healthcare) has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does JBM (Healthcare)'s Dividend Payout Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, JBM (Healthcare) ranks #390 out of 446 companies for Dividend Payout Ratio. This places JBM (Healthcare) in the lower half of its industry. The industry median Dividend Payout Ratio is 0.39. JBM (Healthcare)'s value of 0.93 is 141.6% above this benchmark. Historically, JBM (Healthcare)'s own Dividend Payout Ratio has ranged from 0.09 to 0.86 over the past decade. While the company's 10-year median is 0.41 vs. the industry median of 0.39, JBM (Healthcare) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.39, based on 446 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JBM (Healthcare)'s current Dividend Payout Ratio of 0.93 is 141.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on JBM (Healthcare) and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JBM (Healthcare)'s current Dividend Payout Ratio is 0.93, which is 127% above median its own 10-year median of 0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JBM (Healthcare) stock overvalued right now?
Based on GuruFocus' analysis, JBM (Healthcare) (HKSE:02161) is currently considered Fairly Valued. The stock's GF Value™ is HK$2.08, compared to a current price of HK$1.92 — trading 7.7% below its estimated fair value. The current Dividend Payout Ratio is 0.93, which is 127% above median its 10-year median of 0.41 and 141.6% above the Drug Manufacturers industry median of 0.39. JBM (Healthcare)'s overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For JBM (Healthcare) (HKSE:02161), the current Dividend Payout Ratio is 0.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JBM (Healthcare) (HKSE:02161) Overvalued in 2026?

Based on GuruFocus' analysis, JBM (Healthcare) stock appears to be undervalued. The current stock price of HK$1.92 is trading 7.7% below its estimated GF Value™ of HK$2.08. GuruFocus considers JBM (Healthcare) to be Fairly Valued.

Key valuation signals for HKSE:02161:

  • Dividend Payout Ratio: 0.93 (127% above median its 10-year median of 0.41)
  • GF Value™: HK$2.08 vs. price of HK$1.92 (7.7% below fair value)
  • GF Score™: 86/100 with 4 warning signs
  • Industry Position: 141.6% above the Drug Manufacturers median (#390 of 446)

No single metric tells the full story. See the HKSE:02161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JBM (Healthcare) Business Description

Address 108 Wai Yip Street, Units 808-811, 8 floor, C-Bons International Centre, Kwun Tong, Kowloon, Hong Kong, HKG
JBM (Healthcare) Ltd markets and distributes healthcare products. The company's operating segment includes Branded medicines; Proprietary Chinese medicines and Health and wellness products. It generates maximum revenue from the Proprietary Chinese medicines segment. The Proprietary Chinese medicines segment develops, manufactures, and distributes registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal, or mineral origin customarily or widely used by the Chinese. Geographically, it derives a majority of its revenue from Hong Kong.
86GF Score

Get the complete analysis for HKSE:02161

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.92
Price
HK$2.08
GF Value